We therefore measured HAR1A levels in prostate cancer cells (LNCaP), finding that HAR1A has a higher expression in the prostate cancer cells, compared to GBM and DMG cells (S2B Fig). The gene discussed is HAR1A; the disease is prostate carcinoma.